Together, these results suggest that both soluble huCD147-Strep and an-ti-CD147 block influenza virus adsorption to host cells by disrupting the CD147–HA interaction in a dose-dependent manner and significantly reducing virus proliferation at later stages of infection. Here, BSG is linked to infection.